Designing dendrimers for ocular drug delivery

Eur J Med Chem. 2010 Jan;45(1):326-34. doi: 10.1016/j.ejmech.2009.10.017. Epub 2009 Oct 14.

Abstract

New series of phosphorus-containing dendrimers, having one quaternary ammonium salt as core and carboxylic acid terminal groups have been synthesized from generation 0 (3 carboxylic acid terminal groups) to generation 2 (12 carboxylic acid terminal groups). These dendrimers react with the neutral form of carteolol (an ocular anti-hypertensive drug used to treat glaucoma) to afford ion pair (saline) species. The solubility in water of these charged dendrimers depends on the generation considered: generation 0 (3 carteolol) is well soluble, whereas generation 1 (6 carteolol) and generation 2 (12 carteolol) are poorly soluble. These dendrimers have been tested in vivo, as vehicle for ocular drug delivery of carteolol to rabbits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carboxylic Acids / chemistry
  • Carteolol / chemistry
  • Carteolol / therapeutic use
  • Dendrimers / chemical synthesis
  • Dendrimers / chemistry*
  • Dendrimers / metabolism*
  • Drug Administration Schedule
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry*
  • Drug Carriers / metabolism*
  • Drug Design*
  • Eye / drug effects
  • Eye / metabolism*
  • Female
  • Glaucoma / drug therapy
  • Ocular Hypertension / drug therapy
  • Phosphorus / chemistry
  • Quaternary Ammonium Compounds / chemistry
  • Rabbits
  • Static Electricity

Substances

  • Carboxylic Acids
  • Dendrimers
  • Drug Carriers
  • Quaternary Ammonium Compounds
  • Phosphorus
  • Carteolol